Executive Summary

Five years after Brexit, the industrial policy gap between France and the UK is widening in France’s favor — and France 2030 is the primary reason. The UK’s Industrial Strategy, first published in 2017 and succeeded by the Innovation Strategy (2021) and subsequent iterations under different prime ministers, has never achieved the coherence, funding weight, or political durability of France 2030. Where France committed €54 billion under a single presidential mandate in October 2021, the UK has cycled through multiple industrial strategies under six prime ministers since 2016, each with different priorities and none commanding the scale or longevity of France 2030. The UK’s ambition — becoming a “science superpower” by 2030, with £22 billion in public R&D by 2026/27 — is genuine but narrowly scoped compared to France’s comprehensive reindustrialization agenda. Brexit compounds the disadvantage: UK companies cannot access IPCEI programs, the European Chips Act, the European Defence Fund, or Horizon Europe (rejoined in 2024 but with complications) on the same terms as French companies. On battery manufacturing, the UK has lost every major gigafactory battle to France and Germany. On AI, the UK’s research ecosystem is world-class but its commercial AI champions are thinner than France’s. On nuclear, both countries are committed but France is further ahead. The UK’s competitive advantages — life sciences, fintech, financial services, world-class universities — are real but exist largely outside the domain where France 2030 competes.

Budget and Scale

The UK’s £22 billion R&D target by 2026/27 is the headline commitment from the Innovation Strategy. In practice:

• UKRI (UK Research and Innovation) annual budget: ~£8-9B
• Innovate UK annual budget: ~£1B
• Advanced Research and Invention Agency (ARIA): £800M over 4 years
• UK Infrastructure Bank: £22B in capital (loans + guarantees, not grants)
• Various sector-specific programs (Aerospace Technology Institute, Automotive Transformation Fund, Life Sciences Investment Programme)

The UK has not published a single integrated manufacturing investment plan comparable to France 2030. The closest equivalent is the 2023 “Sunak Industrial Strategy” consultation and the 2024 Labour government’s Industrial Strategy, which identified eight growth sectors but did not attach a consolidated budget.

Total UK manufacturing investment support (France 2030 equivalent): Approximately £12-18 billion over a comparable period, across multiple programs. In euros, this is roughly €14-21 billion — less than half of France 2030’s €54 billion.

GDP comparison:

• UK Innovation/Industrial Strategy spending: ~0.12-0.18% of UK GDP annually
• France 2030: ~0.24% of French GDP annually

France is spending proportionally twice as much on strategic industrial investment as the UK.

Strategic Focus Areas

The UK and France have partially overlapping industrial priorities, but the UK’s strategy is more focused on knowledge economy and R&D-intensive sectors, while France 2030 emphasizes physical manufacturing and hardware sovereignty.

The UK’s battery story is a cautionary tale that illuminates France 2030’s relative success. Britishvolt, the UK’s flagship battery startup that was supposed to build the country’s first gigafactory, went into administration in January 2023. AESC (Envision) is building a factory in Sunderland (Nissan-anchored), and Tata is building a Somerset gigafactory for JLR — but the UK’s total committed capacity lags France significantly. The structural problem: UK companies post-Brexit cannot use EU battery supply chains as seamlessly as French companies, and the UK’s domestic automotive market is insufficient to anchor multiple gigafactories without export access.

Governance and Implementation

The UK’s innovation governance has been its greatest weakness: too many reorganizations, too much ministerial instability, and insufficient policy continuity. Since 2016, the UK has had:

• Six prime ministers
• Four different industrial strategies
• Three different government departments responsible for industrial policy (BEIS, DSIT, DBT, now Department for Business and Trade)
• The creation and dissolution of multiple delivery bodies

France 2030 has operated under the same presidential mandate since October 2021, with a consistent governance structure (SGPI + Bpifrance), consistent budget, and consistent sector priorities. Even through two prime ministerial changes (Borne to Attal to Bayrou) and coalition complications, France 2030 has maintained strategic continuity.

Investor perception: Conversations with investors and corporate strategists consistently identify policy stability as a key factor favoring France over the UK for long-term manufacturing investments. The UK’s reputation for policy reversals — on EV mandates, on planning reform, on tax regimes — has damaged investor confidence in ways that take years to rebuild.

Innovate UK vs Bpifrance: Innovate UK and Bpifrance are both competent institutions, but Bpifrance has a larger balance sheet (€50B+), a broader mandate (grants, equity, guarantees, loans), and operates at significantly greater scale. Innovate UK’s annual budget of ~£1B is modest compared to Bpifrance’s annual grant deployment.

Key Beneficiaries

UK innovation strategy beneficiaries:

• AstraZeneca (life sciences, billions in R&D commitments)
• GSK (vaccine and pharma manufacturing)
• Rolls-Royce (aerospace and SMR nuclear)
• BAE Systems (defense and advanced manufacturing)
• DeepMind / Isomorphic Labs (world-leading AI research)
• Arm Holdings (semiconductor IP — fabless, no manufacturing)
• Darktrace, Improbable, other AI/tech scale-ups

The UK’s innovation ecosystem is genuinely world-class in life sciences, fintech, AI research, and cybersecurity. But these sectors are primarily services and knowledge businesses, not the hardware manufacturing and physical technology sectors France 2030 targets.

France 2030 comparable beneficiaries:

• Mistral AI (frontier language models — commercial champion)
• Verkor, ACC (battery manufacturing)
• STMicro/GlobalFoundries (semiconductor manufacturing)
• Airbus, Safran (aerospace hardware)
• Nuward, NAAREA (nuclear technology)
• Lhyfe, Genvia (hydrogen manufacturing)

The French list is more concentrated in physical technology manufacturing; the UK list more concentrated in software, services, and research. Both are legitimate strategic positions, but France 2030 targets sectors where government capital can most directly enable sovereign hardware capacity.

Results To Date

UK Innovation Strategy (Q1 2026):

• UK remains world’s second AI research ecosystem (behind US, arguably)
• Life sciences investment strong: AstraZeneca’s Cambridge R&D complex world-class
• Battery manufacturing: ~30 GWh committed (significantly behind France’s ~50 GWh)
• Nuclear: Rolls-Royce SMR design progressing, commercial timeline uncertain
• Fintech: London remains top-three global fintech hub
• Semiconductor: No major new fab; UK relies on imports and Arm IP
• R&D spending: Approaching £22B target but composition less manufacturing-focused

France 2030 (Q1 2026):

• ~€30B+ deployed
• Battery: ~50 GWh committed (northern France Battery Valley)
• AI: Mistral AI — Europe’s only credible frontier LLM company
• Nuclear: Multiple SMR programs, EPR2 approved
• Semiconductor: Crolles expansion underway
• Jobs: 200,000+ committed
• Unicorns: France surpassed 40+ technology unicorns

Competitive Implications

Brexit has permanently changed the Franco-UK competitive dynamic in industrial policy:

EU membership advantage for France:

• IPCEI access: France participates in all six major IPCEIs; UK cannot
• European Chips Act: Adds billions to France’s semiconductor program; unavailable to UK
• EU single market: 450 million consumer market for French manufacturers
• Horizon Europe: UK rejoined in 2024 but with complications and delays
• European Defence Fund: France participates fully; UK excluded

UK advantages:

• Financial services (London vs Paris — Paris gaining but London still dominant)
• Life sciences ecosystem (world-class, larger than France)
• US relationship (closer post-Brexit on defense and intelligence)
• Common law legal system (preferred by some multinationals)
• Flexibility outside EU regulatory frameworks

For manufacturing investment decisions — gigafactories, semiconductor fabs, electrolyzer plants — the EU single market access that France offers is increasingly decisive. A battery factory in France can supply the entire EU market; a factory in the UK faces tariffs and regulatory friction on EU exports.

Analyst Assessment

France is significantly outperforming the UK on industrial manufacturing investment, battery capacity, and comprehensive reindustrialization. The UK is outperforming France on life sciences, AI research quality, and financial services — but these are sectors France 2030 does not primarily target.

The Brexit factor is not France’s doing but it is France’s gain. Every major manufacturing investment lost to France at the expense of the UK reinforces France’s industrial base and creates agglomeration effects (skilled workers, supply chains, research partnerships) that compound over time.

The UK’s greatest industrial policy failure of the 2020s is batteries. With three major automotive manufacturers committed to EV production (Nissan, JLR, BMW Mini) and a large domestic car market, the UK should have been a major battery investment destination. Instead, Britishvolt failed, and the UK’s total committed battery capacity is smaller than France’s despite the UK’s automotive manufacturing base.

The UK’s greatest industrial policy success — AI research, life sciences — was largely pre-existing and has been maintained by its university system and the network effects of London, not by a specific industrial strategy.

The verdict: France wins the manufacturing and hardware sovereignty comparison. The UK wins the research and services comparison. For investors in physical industrial assets — batteries, clean energy, nuclear, semiconductors — France offers a superior combination of market access, capital support, and policy stability. For investors in life sciences, AI research, and financial services, the UK remains highly competitive.

Key Data Comparison Table